Have a feature idea you'd love to see implemented?
Let us know!
LFMD LifeMD Inc
Price (delayed)
$5.69
Market cap
$246.45M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.64
Enterprise value
$234M
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable
Highlights
The gross profit has grown by 46% YoY and by 9% from the previous quarter
The revenue has grown by 42% YoY and by 8% from the previous quarter
LifeMD's equity has shrunk by 84% QoQ but it has increased by 39% YoY
The quick ratio has grown by 21% YoY but it has contracted by 8% from the previous quarter
The debt is up by 25% year-on-year and by 21% since the previous quarter
Key stats
What are the main financial stats of LFMD
Market
Valuations
Earnings
Shares outstanding
43.31M
Market cap
$246.45M
Enterprise value
$234M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.21
Revenue
$193.06M
EBIT
-$19.66M
EBITDA
-$10.77M
Free cash flow
$10.63M
Per share
Balance sheet
Liquidity
EPS
-$0.64
Free cash flow per share
$0.25
Book value per share
-$0.18
Revenue per share
$4.59
TBVPS
$1.35
Total assets
$72.56M
Total liabilities
$78.51M
Debt
$25.14M
Equity
-$7.72M
Working capital
-$10.3M
Debt to equity
-3.26
Current ratio
0.83
Quick ratio
0.74
Net debt/EBITDA
1.16
Margins
Efficiency
Dividend
EBITDA margin
-5.6%
Gross margin
89.6%
Net margin
-11.7%
Operating margin
-10%
Return on assets
-40%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-144.5%
Return on sales
-10.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFMD stock price
How has the LifeMD stock price performed over time
Intraday
4.98%
1 week
-4.69%
1 month
26.73%
1 year
-18.71%
YTD
-31.36%
QTD
8.59%
Financial performance
How have LifeMD's revenue and profit performed over time
Revenue
$193.06M
Gross profit
$173.06M
Operating income
-$19.33M
Net income
-$22.51M
Gross margin
89.6%
Net margin
-11.7%
The gross profit has grown by 46% YoY and by 9% from the previous quarter
LFMD's operating margin is up by 46% year-on-year and by 7% since the previous quarter
The net margin is up by 45% year-on-year and by 11% since the previous quarter
The revenue has grown by 42% YoY and by 8% from the previous quarter
Growth
What is LifeMD's growth rate over time
Valuation
What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.21
The EPS has grown by 35% YoY and by 9% from the previous quarter
LifeMD's equity has shrunk by 84% QoQ but it has increased by 39% YoY
The revenue has grown by 42% YoY and by 8% from the previous quarter
The P/S is 35% below the 5-year quarterly average of 1.9 and 31% below the last 4 quarters average of 1.8
Efficiency
How efficient is LifeMD business performance
LFMD's ROA has soared by 57% year-on-year and by 16% since the previous quarter
The ROS has grown by 46% YoY and by 12% from the previous quarter
Dividends
What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFMD.
Financial health
How did LifeMD financials performed over time
LifeMD's total assets is 8% less than its total liabilities
LifeMD's total assets has soared by 78% YoY and by 14% from the previous quarter
LFMD's total liabilities has soared by 52% year-on-year and by 19% since the previous quarter
LFMD's debt to equity has dropped by 105% year-on-year but it is up by 34% since the previous quarter
LifeMD's equity has shrunk by 84% QoQ but it has increased by 39% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.